Aurobindo Pharma share price has gained 4% in one month, but the stock has dropped nearly 10% on a year-to-date (YTD) basis.

Aurobindo Pharma's Penicillin-G plant in Kakinada, operated by Lyfius Pharma, has temporarily suspended production following ...

Aurobindo Pharma reported a fire at its Penicillin-G facility in Kakinada SEZ, damaging ancillary equipment but sparing core ...

Aurobindo Pharma reports fire incident at Penicillin-G facility, operations suspended for 20-25 days, no injuries, minimal ...

The fire occurred at around 10 pm in the company's penicillin-G manufacturing facility in Kakinada SEZ, Andhra Pradesh. No ...

Aurobindo Pharma reports a fire incident at its subsidiary Lyfius Pharma's plant in Andhra Pradesh, leading to a temporary ...

Shares of Aurobindo Pharma fell over 3% on April 29 after the company reported fire incident at its coal crusher area in ...

CuraTeQ Biologics s.r.o., announced that the CHMP of the European Medicines Agency has adopted a positive opinion ...

Vedanta reported its revenue revenue grew by 14 percent to Rs 40,455 crore, over Rs 35,509 crore in the corresponding quarter ...

Aurobindo Pharma's biosimilar for breast cancer recommended for EU approval, demonstrating similarity to Herceptin.

Pharma stocks Zydus Life, Aurobindo Pharma and Biocon gained up to nearly 3% in trade after they secured regulatory approvals ...

Aurobindo Pharma declined 2.97% to Rs 1,209.70 after the company disclosed a fire incident at the manufacturing facility of its subsidiary, Lyfius Pharma, located in Andhra Pradesh.